bluebird bio Dividend
Dividend criteria checks 0/6
bluebird bio does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Payout ratio
Industry average yield | 2.9% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Earnings per share | -US$0.47 |
Dividend yield forecast in 3Y | 0% |
Recent dividend updates
No updates
Recent updates
bluebird bio Is Priced Below IP Value
Mar 23Bluebird Bio: Innovative Therapies, Monetary Setbacks
Jan 25Is bluebird bio (NASDAQ:BLUE) In A Good Position To Invest In Growth?
Oct 13Here's Why We're A Bit Worried About bluebird bio's (NASDAQ:BLUE) Cash Burn Situation
Jul 13Bluebird, Real Endpoints team up to increase access to pricey gene therapy Zynteglo
Oct 04Bluebird bio names interim finance chief
Sep 26Bluebird bio jumps 17% on FDA approval of new gene therapy
Sep 19bluebird bio' chief strategy and financial officer to depart
Sep 12FDA approves bluebird bio's Zyntego beti-cel gene therapy for beta thalassemia
Aug 17bluebird bio: Potential For 3 Gene Therapy Approvals In 12 Months Makes Buy Case
Jun 22bluebird bio: Beaten Down Biotech With Possible Long-Term Potential
May 09Bluebird Bio: Gene Therapy Launches Could Bring Big Revenues, Providing They Meet Approval
Feb 07bluebird bio: Ticker Fueled By Gambling Chance Of Commercial Success
Dec 12bluebird bio (NASDAQ:BLUE) Will Have To Spend Its Cash Wisely
Nov 08bluebird bio: Like A Bird In The Middle Of The Deep Blue Sea
Nov 03Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if BLUE's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if BLUE's dividend payments have been increasing.
Dividend Yield vs Market
bluebird bio Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (BLUE) | n/a |
Market Bottom 25% (US) | 1.5% |
Market Top 25% (US) | 4.7% |
Industry Average (Biotechs) | 2.9% |
Analyst forecast in 3 Years (BLUE) | 0% |
Notable Dividend: Unable to evaluate BLUE's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate BLUE's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate BLUE's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as BLUE has not reported any payouts.